|Day Low/High||14.00 / 14.05|
|52 Wk Low/High||8.28 / 16.15|
Affymetrix, Inc. (NASDAQ: AFFX) today announced that it has delivered the first custom array designed for a 100,000-sample genotyping project to be performed using the Axiom™ Genotyping Solution.
Family Tree DNA, the first and largest genealogical DNA testing company, today announced the launch of the Family Finder DNA test for connecting family members across all ancestral lines.
Affymetrix, Inc. (NASDAQ:AFFX) today announced the webcast of its presentation at the Deutsche Bank Securities 35 th Annual Health Care Conference in Boston.
Affymetrix, Inc. (NASDAQ:AFFX) today announced the launch of the Axiom™ Genome-Wide ASI Array, the first commercial product to provide maximum power for genome-wide association studies (GWAS) in East Asian ...
Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the first quarter of 2010.
Affymetrix, Inc. (NASDAQ:AFFX) today announced the launch of the Affymetrix® MIP Copy Number Service, designed for cancer researchers using challenging FFPE samples.
Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will release operating results for the first quarter after close of the stock market on Wednesday, April 21, 2010.
Affymetrix, Inc. (NASDAQ:AFFX) and The Jackson Laboratory today announced the full commercial launch of the Affymetrix® Mouse Diversity Genotyping Array.
Affymetrix, Inc. (NASDAQ:AFFX) today announced that Timothy Barabe has been appointed Executive Vice President and Chief Financial Officer of the company.
Affymetrix, Inc. (NASDAQ:AFFX) announced today that Jami Dover Nachtsheim and Nelson C.
Affymetrix, Inc. (NASDAQ:AFFX) today announced that company management will provide a corporate overview at two upcoming financial conferences.
Affymetrix, Inc. (NASDAQ: AFFX) today announced the launch of the GeneAtlas™ System, a complete, personal solution for processing Affymetrix arrays and characterizing changes in gene expression in a variety of...
Affymetrix, Inc. (Nasdaq: AFFX) today announced that Professor Tom Rapoport of Harvard Medical School and Howard Hughes Medical Institute is the winner of the 2010 Anatrace Membrane Protein Award.
Several stocks trading near $5 were poised to move on above-average volume during Thursday's session.
Several stocks trading near $5 were poised to move on above-average volume during Wednesday's session.
Merck is upgraded at Credit Suisse to Outperform from Neutral.
Affymetrix and TessArrae say FDA grants emergency marketing approval for RM-Flu swine flu test
Xerox, AT&T, Kimberly-Clark, Fifth Third, Amgen are among big market movers Thursday
Affymetrix shares slide; analyst says weak genotyping sales hurt 3rd qtr results and outlook
Affymetrix reports smaller 3rd-quarter loss, but results miss estimates, shares tumble
Keep an eye out for any stocks or sectors that are moving their own way. That should be an easy chore.
Influential senators in health care overhaul have ties with some of biggest names in industry
Affymetrix shares fall following report of 1st-quarter loss as revenue plunges
Dionex appoints Frank Witney of Affymetrix as new president and chief executive
"Loser" stocks to champion, and why you should pay attention to insider buying right now.
Shares of the popular shoemaker, Crocs, shed after reporting softened second-quarter profit and sales outlook, leading to an analyst downgrade.
Frank Curzio reviews the action with guests Mike Comeau, who discusses Intel, and Larsen Kusick, who waxes on Crocs.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.